Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference |
| January 11, 2021 | January 2021 Bond Updates |
|
Commercial launch activities for Idefirix® progressing as planned Patient recruitment in the two phase 2 studies in AMR and GBS was reinitiated in December 2020 Year-end cash position of SEK 1.4 billion LUND, Sweden, Jan. 11, 2021 /PRNewswire/ -- Hansa Biopharma, the leader in... |
| View more at: https://www.prnewswire.com:443/news-releases/hansa-biopharma-provides-business-update-incl-certain-key-financials-ahead-of-the-jp-morgan-global-healthcare-conference-301204955.html |
| Related News |
|